A Compassionate Access Protocol For Those Patients Who Have Completed A4001029

Summary

This is a compassionate study to provide continued access to maraviroc for only those subjects completing study A4001029 who are showing clinical benefit. Assessments of safety and tolerability of maraviroc when added to OBT will be continued.

Timeline

Start

2009-08

Primary completion

2011-07

Completion

2011-07

Drugs

Indications